Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Tamberi S"" wg kryterium: Autor


Wyświetlanie 1-2 z 2
Tytuł:
AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer.
Autorzy:
Antoniotti C; Department of Oncology, University Hospital of Pisa, Pisa, Italy.; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
Borelli B; Department of Oncology, University Hospital of Pisa, Pisa, Italy.; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
Rossini D; Department of Oncology, University Hospital of Pisa, Pisa, Italy.; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
Pietrantonio F; Oncology and Hemato-Oncology Department, University of Milan, Milano, Italy.; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Morano F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Salvatore L; Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.; Università Cattolica del Sacro Cuore, Roma, Italy.
Lonardi S; Medical Oncology Unit 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto - IRCCS, Padova, Italy.
Marmorino F; Department of Oncology, University Hospital of Pisa, Pisa, Italy.; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
Tamberi S; Medical Oncology, Ospedale degli Infermi, Faenza, Italy.
Corallo S; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Tortora G; Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.; Università Cattolica del Sacro Cuore, Roma, Italy.
Bergamo F; Medical Oncology Unit 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto - IRCCS, Padova, Italy.
Brunella DS; Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.; Università Cattolica del Sacro Cuore, Roma, Italy.
Boccaccino A; Department of Oncology, University Hospital of Pisa, Pisa, Italy.; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
Grassi E; Medical Oncology, Ospedale degli Infermi, Faenza, Italy.
Racca P; SSD ColoRectal Cancer Unit, Department of Oncology, AOU Città della Salute e della Scienza di Torino, Torino, Italy.
Tamburini E; Department of Oncology and Palliative Care, Cardinale G. Panico, Tricase City Hospital, Tricase, Italy.
Aprile G; Department of Oncology, San Bortolo General Hospital, ULSS8 Berica, East District, Vicenza, Italy.
Moretto R; Department of Oncology, University Hospital of Pisa, Pisa, Italy.
Boni L; Clinical Trials Coordinating Center, Toscano Cancer Institute, University Hospital Careggi, Firenze, Italy.
Falcone A; Department of Oncology, University Hospital of Pisa, Pisa, Italy.; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
Cremolini C; Department of Oncology, University Hospital of Pisa, Pisa, Italy. .; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2020 Jul 22; Vol. 20 (1), pp. 683. Date of Electronic Publication: 2020 Jul 22.
Typ publikacji:
Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Antibodies, Monoclonal, Humanized/*administration & dosage
Antineoplastic Agents/*administration & dosage
Antineoplastic Agents, Immunological/*administration & dosage
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Bevacizumab/*administration & dosage
Camptothecin/*analogs & derivatives
Colorectal Neoplasms/*drug therapy
Aged ; Camptothecin/administration & dosage ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/pathology ; Drug Administration Schedule ; Fluorouracil/administration & dosage ; Humans ; Italy ; Leucovorin/administration & dosage ; Microsatellite Instability ; Organoplatinum Compounds/administration & dosage ; Prospective Studies
SCR Protocol:
FOLFOXIRI protocol
Czasopismo naukowe
Tytuł:
Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC).
Autorzy:
Cappuzzo F; Bellaria Hospital, Division of Medical Oncology, Via Altura 3, Bologna 40139, Italy. />Bartolini S
Ceresoli GL
Tamberi S
Spreafico A
Lombardo L
Gregorc V
Toschi L
Calandri C
Villa E
Crinò L
Pokaż więcej
Źródło:
British journal of cancer [Br J Cancer] 2004 Jan 12; Vol. 90 (1), pp. 82-6.
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study
MeSH Terms:
Aging*
Antineoplastic Agents/*pharmacology
Carcinoma, Non-Small-Cell Lung/*drug therapy
Lung Neoplasms/*drug therapy
Quinazolines/*pharmacology
Aged ; Aged, 80 and over ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Carcinoma, Non-Small-Cell Lung/pathology ; Diarrhea/chemically induced ; Female ; Gefitinib ; Humans ; Lung Neoplasms/pathology ; Male ; Quinazolines/adverse effects ; Quinazolines/therapeutic use ; Skin Diseases/chemically induced
Czasopismo naukowe
    Wyświetlanie 1-2 z 2

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies